Aldeyra Therapeutics Priced, Nasdaq: ALDX
Clinical-stage biotech developing treatments for rare skin and eye diseases.
Industry: Health Care
First Day Return: -10.0%
ALDX
Clinical-stage biotech developing treatments for rare skin and eye diseases.
| IPO Data | |
|---|---|
| IPO Date | 05/01/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $12 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Burlington, MA, United States |
| Founded | 2004 |
| Employees at IPO | 2 |
| Website www.aldexatherapeutics.com | |
IPO News for Aldeyra Therapeutics
Aldeyra Therapeutics (ALDX) Performance
